Metabolic Syndrome (Syndrome X) and Other Types of Cancer

Insulin Resistance-related Metabolic Syndrome, which can cause Cardiovascular Disease resulting in a heart attack or stroke, is also being increasingly linked by researchers to numerous types of cancer. These include breast, pancreatic and colon cancer. Studies are also beginning to link excess abdominal fat with a greater risk of some cancers. Although the link is not yet clearly understood, scientists believe that higher levels of glucose and insulin in the blood stream – two of the hallmarks of Insulin Resistance and Metabolic Syndrome – somehow stimulate cancer cell growth. In women after menopause, excessive abdominal weight doubles the risk of breast cancer regardless of overall weight. Scientists believe that the components of Insulin Resistance and Metabolic Syndrome – hyperinsulinemia, dyslipidemia, hypertension (high blood pressure) and atherosclerosis — actually favor the growth of breast cancer cells, creating an environment ripe for the development of this disease. Researchers at the University of Buffalo, New York, were among the first to show that Insulin Resistance may significantly increase the risk of death from colon cancer, particularly among women (1). There is also strong evidence that women with PCOS (Polycystic Ovarian Syndrome) are at higher risk of developing endometrial and ovarian cancer (2). Click here to read about the ground-breaking Insulite MetaX System, which is scientifically designed to help reverse obesity-related Insulin Resistance, a factor that has been linked to various forms of cancer as well as Cardiovascular Disease. The system includes numerous formulations, including Meta RejuvenX with ingredients like Quercitin, which contains antioxidant, anticarcinogenic and antiinflammatory properties to inhibit cell-damaging free radical production. You may be interested in some of our Frequently Asked Questions (FAQs) on Metabolic Syndrome and the Insulite MetaX System. How does the Insulite MetaX System help people suffering from the disorder? Are there any stimulants in the Insulite MetaX System products? How long do I stay on the Insulite MetaX System? (1) Risk Factors and Life Expectancy Project, University of Buffalo, results presented at the annual meeting of the Society for Epidemiological Research. - Paolo Muti MD, Jain Liu, Maurizio Trevisan MD, Alessandro Menotti, University of Buffalo (2) Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women.Carmina E, Lobo RA. J Clin Endocrinol Metab. 1999 Jun;84(6):1897-9. Click here to read about Insulin Resistance, Metabolic Syndrome and Serious Conditions Return to Home Page